25 /100
LOW RISK
Score updated Apr 13, 2026

NTLA

Intellia Therapeutics, Inc. — Stock Dilution Tracker

Track NTLA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track NTLA — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
30
💰 Cash Runway
25
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
9%
💰 Capital Raise 18%
• Active ATM program with $400M remaining capacity
🔔 Track NTLA — Get forecast alerts →
💹 Market Data
Market Cap$1.59B
Shares Outstanding118.13M
Float111.94M
Cash$449.88M
Debt$93.33M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 0.0% shares (2025Q4 vs prior)
296 institutional holders · 111.28M shares
#1 ARK Investment Management LLC 14.21M shares
#2 VANGUARD GROUP INC 13.01M shares
#3 BlackRock, Inc. 10.28M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest38.95M
Days to Cover10.8
% of Float34.8%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Mar 03, 2026
4 INSIDER TRANSACTION Mar 03, 2026
Full SEC filing analysis available with free account
📰 Recent News
Track NTLA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NTLA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required